Although STIC has been recognized as a precursor lesion of serous carcinoma, it has been reported that a single-cell epithelial layer with strong p53 immunoreactivity, named the p53 signature, was identified in benign fimbriae regardless of BRCA mutations [92]. Here, TP53 is linked to serous adenocarcinoma.